Loading...
Oligosaccharides Isolated from MGO™ Manuka Honey Inhibit the Adhesion of Pseudomonas aeruginosa, Escherichia Coli O157:H7 and Staphylococcus Aureus to Human HT-29 cells
Lane, Johnathan A. ; Calonne, Julie ; Slattery, Helen ; Hickey, Rita M.
Lane, Johnathan A.
Calonne, Julie
Slattery, Helen
Hickey, Rita M.
Citations
Altmetric:
Date
2019-10-01
Collections
Files
Loading...
main article
Adobe PDF, 2.55 MB
Research Projects
Organizational Units
Journal Issue
Citation
Lane, J.A.; Calonne, J.; Slattery, H.; Hickey, R.M. Oligosaccharides Isolated from MGO™ Manuka Honey Inhibit the Adhesion of Pseudomonas aeruginosa, Escherichia Coli O157:H7 and Staphylococcus Aureus to Human HT-29 cells. Foods 2019, 8, 446. https://doi.org/10.3390/foods8100446
Abstract
Historically, honey is known for its anti-bacterial and anti-fungal activities and its use
for treatment of wound infections. Although this practice has been in place for millennia, little
information exists regarding which manuka honey components contribute to the protective nature
of this product. Given that sugar accounts for over 80% of honey and up to 25% of this sugar is
composed of oligosaccharides, we have investigated the anti-infective activity of manuka honey
oligosaccharides against a range of pathogens. Initially, oligosaccharides were extracted from a
commercially-available New Zealand manuka honey—MGO™ Manuka Honey (Manuka Health New
Zealand Ltd.)—and characterized by High pH anion exchange chromatography coupled with pulsed
amperiometric detection. The adhesion of specific pathogens to the human colonic adenocarcinoma
cell line, HT-29, was then assessed in the presence and absence of these oligosaccharides. Manuka
honey oligosaccharides significantly reduced the adhesion of Escherichia coli O157:H7 (by 40%),
Staphylococcus aureus (by 30%), and Pseudomonas aeruginosa (by 52%) to HT-29 cells. This activity was
then proven to be concentration dependent and independent of bacterial killing. This study identifies
MGO™ Manuka Honey as a source of anti-infective oligosaccharides for applications in functional
foods aimed at lowering the incidence of infectious diseases.
